» Articles » PMID: 19490564

Comparison of Different Valuation Methods for Population Health Status Measured by the EQ-5D in Three European Countries

Overview
Journal Value Health
Publisher Elsevier
Date 2009 Jun 4
PMID 19490564
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to analyze and compare different valuation methods for population health status measured by the EuroQol-5D (EQ-5D) in three European countries.

Methods: A representative survey of the noninstitutionalized population aged 18 and above was conducted in three European countries (Germany, The Netherlands, and Spain). A total of 11,932 respondents were interviewed using the EQ-5D self-classifier. Health state values based on community preferences (EQ-5D index) were calculated for each country using four different value sets: national value sets based on the time trade-off (TTO) and the visual analogue scale (VAS), the UK TTO-based value set and the European VAS-based value set. Linear regression analysis was conducted to evaluate the factors associated with different EQ-5D index scores depending on the value set used. Loss of quality-adjusted life-years (QALYs) was calculated for each country using the four value sets by multiplying the age and gender-specific values with the respective population size.

Results: In all countries, means of all EQ-5D index scores were higher for men than women, and decreased with age. Index scores calculated using the national value set based on TTO were higher than those calculated using the UK TTO-based value set and, also, slightly higher than those calculated using the European VAS-based value set or the national value set based on the VAS. The mean loss of QALYs estimated for Germany per inhabitant varied between 0.062 (national value set based on TTO) and 0.094 (European VAS-based value set). In The Netherlands, the mean loss of QALYs per inhabitant ranged from 0.090 (national value set based on TTO) to 0.125 (national value set based on VAS). In Spain, the mean loss of QALYs per inhabitant ranged between 0.072 (national value set based on TTO) and 0.085 (European VAS-based value set).

Conclusions: In general, the differences among countries and valuations were rather small; nevertheless, some important variations should be taken into account while applying different valuation methods to the EQ-5D descriptive system. The associations between sociodemographic variables and health state scores remained the same across countries regardless of which value sets were used. Using different valuation methods lead to different QALY losses. To overcome this problem in international surveys aimed to compare health state scores or QALYs, it is advisable to use a single valuation method, making these scores comparable.

Citing Articles

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN).

Girardin F, Nicolet A, Bestard O, Lefaucheur C, Budde K, Halleck F Front Pharmacol. 2023; 14:1040584.

PMID: 37180729 PMC: 10174308. DOI: 10.3389/fphar.2023.1040584.


Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study.

Sprave T, Gkika E, Verma V, Grosu A, Stoian R BMC Cancer. 2022; 22(1):1236.

PMID: 36447175 PMC: 9710161. DOI: 10.1186/s12885-022-10346-4.


Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.

Laszewska A, Sajjad A, Busschbach J, Simon J, Roijen L Pharmacoeconomics. 2022; 40(12):1221-1234.

PMID: 36201130 PMC: 9534733. DOI: 10.1007/s40273-022-01194-y.


Consequences of cervical pessary for subsequent pregnancy: follow-up of randomized clinical trial (ProTWIN).

van Limburg Stirum E, Zegveld S, Simons N, de Boer M, Pajkrt E, Mol B Ultrasound Obstet Gynecol. 2021; 59(6):771-777.

PMID: 34826166 PMC: 9328140. DOI: 10.1002/uog.24821.


Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.

Teni F, Rolfson O, Berg J, Leidl R, Burstrom K J Clin Med. 2021; 10(18).

PMID: 34575317 PMC: 8471757. DOI: 10.3390/jcm10184205.